UroToday.com - One of the obvious limitations of the ablative technologies (radiofrequency ablation (RFA) and cryotherapy) is the reliance on radiographic criteria (lack of enhancement) to define success and effective tumor ablation. Recent reports of persistent viable tumor in tumors resected for a variety of indications after ablative therapy have hampered the widespread acceptance of these technologies into general practice. [click link for full article]